valine and Hyperplasia

valine has been researched along with Hyperplasia in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19905 (35.71)18.7374
1990's1 (7.14)18.2507
2000's5 (35.71)29.6817
2010's3 (21.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aguirre, SA; Burns-Naas, LA; Denlinger, RH; Han, B; Hosea, NA; Liu, L; May, JR; Randolph, S; Scott, W1
Sakaida, H; Sano, T; Suzuki, H; Taki, W; Toma, N; Umeda, Y; Yamamoto, A1
Cai, S; Li, Y; Liu, X; Ren, B; Sun, T; Wang, Q; Xu, Q; Yu, H; Zhou, J1
deBlois, D; Der Sarkissian, S; Duguay, D; Hamet, P; Marchand, EL1
CARNEVALI, R; POLI, E; RAINERI, P1
Fujita, T; Goto, A; Hirata, Y; Nagai, R; Nishimatsu, H; Oba, S; Omata, M; Satonaka, H; Suzuki, E; Takeda, R1
Chen, H; Ding, RJ; Jia, SQ; Li, GH; Li, HW; Wang, L; Yao, DK; Zhao, L1
Guan, YY; Liu, YJ; Lu, HH; Sheng, ZQ; Wang, Y; Zhang, L1
Dirnhofer, S; Hao-Shen, H; Looser, R; Schwaller, J; Skoda, RC; Sobas, MA; Tiedt, R1
Scott, EB1
Metcalfe, DD; Shah, PY; Sharma, V; Worobec, AS; Zwick, DC1
Levine, GM; Pusateri, JP; Weinberg, LM1
Arant, BS; Brackett, NC; Still, WJ; Young, RB1
Goldwasser, E; Gross, M1

Other Studies

14 other study(ies) available for valine and Hyperplasia

ArticleYear
Intermittent oral coadministration of a gamma secretase inhibitor with dexamethasone mitigates intestinal goblet cell hyperplasia in rats.
    Toxicologic pathology, 2014, Volume: 42, Issue:2

    Topics: Administration, Oral; Amyloid Precursor Protein Secretases; Animals; Body Weight; Dexamethasone; Goblet Cells; Hyperplasia; Intestines; Male; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Valine

2014
Valsartan prevents neointimal hyperplasia after carotid artery stenting by suppressing endothelial cell injuries.
    Neurological research, 2015, Volume: 37, Issue:1

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Calcium Channel Blockers; Carotid Arteries; Carotid Stenosis; Endothelial Cells; Female; Humans; Hyperplasia; Hypertension; Male; Prospective Studies; Stents; Tetrazoles; Treatment Outcome; Ultrasonography; Valine; Valsartan

2015
Valsartan decreases neointimal hyperplasia in balloon-injured rat aortic arteries by upregulating HO-1 and inhibiting angiotensin II type 1 receptor.
    Life sciences, 2014, Aug-21, Volume: 110, Issue:2

    Topics: Analysis of Variance; Angioplasty, Balloon, Coronary; Animals; Aorta, Thoracic; Bilirubin; DNA Primers; Gene Expression Regulation; Heme Oxygenase-1; Hyperplasia; Male; Neointima; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Valine; Valsartan

2014
Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril.
    Cardiovascular research, 2003, Volume: 57, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Enalapril; Fibroblasts; Heart Ventricles; Hyperplasia; Hypertension; Hypertrophy, Left Ventricular; In Situ Nick-End Labeling; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Valine; Valsartan

2003
[HYPOGLYCEMIC REACTION TO LEUCINE, VALINE AND PHENYLALANINE IN A CASE OF DIFFUSE HYPERPLASIA OF THE BETA CELLS].
    Folia endocrinologica, 1963, Volume: 16

    Topics: Glucose Tolerance Test; Humans; Hyperinsulinism; Hyperplasia; Hypoglycemia; Hypoglycemic Agents; Insulin-Secreting Cells; Islands; Islets of Langerhans; Leucine; Pathology; Pharmacology; Phenylalanine; Tolbutamide; Valine

1963
Calcineurin promotes the expression of monocyte chemoattractant protein-1 in vascular myocytes and mediates vascular inflammation.
    Circulation research, 2004, Mar-19, Volume: 94, Issue:5

    Topics: Angiotensin II; Animals; Calcineurin; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomyopathy, Hypertrophic; Cells, Cultured; Chemokine CCL2; Cyclosporine; Femoral Artery; Gene Expression Regulation; Humans; Hyperplasia; Imidazoles; Macrophages; MAP Kinase Kinase 6; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Promoter Regions, Genetic; Protein Biosynthesis; Proteins; Pyridines; Rats; Recombinant Fusion Proteins; RNA, Messenger; Signal Transduction; Tetrazoles; Transcription, Genetic; Tunica Intima; Valine; Valsartan; Vasculitis

2004
[Valsartan eluting-stents inhibited neointimal hyperplasia by decreasing collagen deposition in rabbits].
    Zhonghua xin xue guan bing za zhi, 2006, Volume: 34, Issue:5

    Topics: Animals; Collagen; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Hyperplasia; Male; Rabbits; Tetrazoles; Tunica Intima; Valine; Valsartan

2006
[Effect of valsartan on neointimal proliferation and expression of vWF after balloon angioplasty in rabbits].
    Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, 2007, Volume: 19, Issue:11

    Topics: Angioplasty, Balloon; Animals; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Hyperplasia; Male; Postoperative Period; Rabbits; Random Allocation; Tetrazoles; Tunica Intima; Valine; Valsartan; von Willebrand Factor

2007
Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice.
    Blood, 2008, Apr-15, Volume: 111, Issue:8

    Topics: Animals; Colony-Forming Units Assay; Granulocytes; Hematopoiesis, Extramedullary; Humans; Hyperplasia; Integrases; Janus Kinase 2; Megakaryocytes; Mice; Mice, Transgenic; Mutant Proteins; Myeloproliferative Disorders; Phenotype; Phenylalanine; Polycythemia Vera; Primary Myelofibrosis; Recombination, Genetic; Thrombocythemia, Essential; Transgenes; Valine

2008
Nodular hyperplasia in thyroids of aged rats fed normal or valine-deficient diets.
    Archives of pathology, 1967, Volume: 84, Issue:6

    Topics: Age Factors; Animals; Deficiency Diseases; Hyperplasia; Rats; Thyroid Diseases; Valine

1967
Congenital bullous mastocytosis with myeloproliferative disorder and c-kit mutation.
    Journal of the American Academy of Dermatology, 1998, Volume: 39, Issue:1

    Topics: Aspartic Acid; Bone Marrow; Fatal Outcome; Granulocytes; Humans; Hyperplasia; Infant, Newborn; Leukocytosis; Male; Mast Cells; Myeloproliferative Disorders; Point Mutation; Proto-Oncogene Proteins c-kit; Urticaria Pigmentosa; Valine

1998
Comparison of different caloric substrates on intestinal adaptation in the rat.
    Gastroenterology, 1989, Volume: 96, Issue:6

    Topics: Adaptation, Physiological; Animals; Aspartic Acid; Dietary Carbohydrates; Dietary Fats; Emulsions; Fat Emulsions, Intravenous; Glucose; Hyperplasia; Ileum; Intestinal Absorption; Intestinal Mucosa; Jejunum; Male; Phospholipids; Rats; Rats, Inbred Strains; Soybean Oil; Triglycerides; Valine

1989
Case studies of siblings with juxtaglomerular hyperplasia and secondary aldosteronism associated with severe azotemia and renal rickets--Bartter's syndrome or disease?
    Pediatrics, 1970, Volume: 46, Issue:3

    Topics: Aldosterone; Alkalosis; Angiotensin II; Bone Diseases; Child; Child, Preschool; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Kidney Glomerulus; Male; Spironolactone; Triamterene; Valine

1970
On the mechanism of erythropoietin-induced differentiation. IX. Induced synthesis of 9 S ribonucleic acid and of hemoglobin.
    The Journal of biological chemistry, 1971, Apr-25, Volume: 246, Issue:8

    Topics: Animals; Bone Marrow; Bone Marrow Cells; Carbon Isotopes; Cell Differentiation; Centrifugation, Density Gradient; Culture Techniques; Erythropoietin; Female; Glycine; Hemoglobins; Hyperplasia; Iron Isotopes; Male; Mice; Polycythemia; Rats; RNA; RNA, Messenger; Time Factors; Valine

1971